Company logo

LQDA - Liquidia Corporation

NASDAQ -> Healthcare -> Biotechnology
Morrisville, United States
Type: Equity

LQDA price evolution
LQDA
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $83.68 $76.22 $88.2 $94.41
Short term investments
Net receivables $4.06 $3.34 $4.09 $4.13
Inventory
Total current assets $89.9 $82.98 $92.89 $99.69
Long term investments
Property, plant & equipment $6.18 $6.21 $6.08 $6.36
Goodwill & intangible assets $7.33 $7.39 $7.46 $7.55
Total noncurrent assets $28.43 $28.66 $28.7 $29.23
Total investments
Total assets $118.33 $111.64 $121.6 $128.92
Current liabilities
Accounts payable $1.4 $1.81 $1.92 $0.84
Deferred revenue
Short long term debt $3.75 $3.72 $2.81 $3.03
Total current liabilities $18.55 $12.16 $19.5 $6.82
Long term debt $45.78 $44.78 $34.75 $33.85
Total noncurrent liabilities $52.49 $51.48 $41.45 $40.46
Total debt $49.54 $48.5 $37.56 $36.88
Total liabilities $71.04 $63.63 $60.94 $47.28
Shareholders' equity
Retained earnings -$429.1 -$401.65 -$385.86 -$362.34
Other shareholder equity
Total shareholder equity $47.29 $48.01 $60.66 $81.64
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $83.68 $93.28 $57.49 $65.32
Short term investments
Net receivables $4.06 $5.02 $2.99
Inventory
Total current assets $89.9 $99.81 $61.28 $66.07
Long term investments
Property, plant & equipment $6.18 $6.25 $7.43 $9.45
Goodwill & intangible assets $7.33 $7.63 $8.29 $9.44
Total noncurrent assets $28.43 $29.39 $32.45 $33.46
Total investments
Total assets $118.33 $129.2 $93.73 $99.53
Current liabilities
Accounts payable $1.4 $2.2 $1.07 $3.73
Deferred revenue
Short long term debt $3.75 $1.08 $1.09 $1.59
Total current liabilities $18.55 $8.8 $7.33 $11.74
Long term debt $45.78 $20.05 $14.99 $15.55
Total noncurrent liabilities $52.49 $29.98 $21.14 $16.71
Total debt $49.54 $24.46 $16.08 $17.14
Total liabilities $71.04 $38.78 $28.46 $28.45
Shareholders' equity
Retained earnings -$429.1 -$350.6 -$309.58 -$275
Other shareholder equity
Total shareholder equity $47.29 $90.42 $65.27 $71.09
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $4.53 $3.68 $4.79 $4.49
Cost of revenue $0.99 $0.57 $0.67 $0.65
Gross Profit $3.54 $3.11 $4.12 $3.84
Operating activities
Research & development $12.83 $7.44 $17.7 $5.28
Selling, general & administrative $17.14 $10.56 $9.24 $7.79
Total operating expenses $29.97 $18 $26.94 $13.07
Operating income -$26.44 -$14.89 -$22.82 -$9.23
Income from continuing operations
EBIT -$25.49 -$14.03 -$22.09 -$10.62
Income tax expense
Interest expense $1.96 $1.76 $1.43 $1.12
Net income
Net income -$27.45 -$15.79 -$23.52 -$11.74
Income (for common shares) -$27.45 -$15.79 -$23.52 -$11.74
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $17.49 $15.94 $12.85 $0.74
Cost of revenue $2.89 $2.86 $3.02 $0.24
Gross Profit $14.6 $13.08 $9.83 $0.5
Operating activities
Research & development $43.24 $19.43 $20.52 $32.22
Selling, general & administrative $44.74 $32.41 $23.11 $27.37
Total operating expenses $87.98 $51.85 $43.63 $59.59
Operating income -$73.38 -$38.77 -$33.8 -$59.09
Income from continuing operations
EBIT -$72.23 -$38.68 -$33.76 -$58.9
Income tax expense
Interest expense $6.27 $2.34 $0.82 $0.86
Net income
Net income -$78.5 -$41.02 -$34.58 -$59.76
Income (for common shares) -$78.5 -$41.02 -$34.58 -$59.76
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$27.45 -$15.79 -$23.52 -$11.74
Operating activities
Depreciation $0.61 $0.62 $0.69 $0.66
Business acquisitions & disposals
Stock-based compensation $2.55 $2.49 $2.5 $2.55
Total cash flows from operations -$15.98 -$11.56 -$5.56 -$8.46
Investing activities
Capital expenditures -$0.21 -$0.47 -$0.24 -$0.36
Investments
Total cash flows from investing -$0.21 -$10.47 -$0.24 -$0.36
Financing activities
Dividends paid
Sale and purchase of stock $24.32 $0.65 $0.03 $0.41
Net borrowings -$0.68 $9.4 -$0.53 $11.71
Total cash flows from financing $23.64 $10.06 -$0.41 $9.95
Effect of exchange rate
Change in cash and equivalents $7.45 -$11.97 -$6.22 $1.13
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$78.5 -$41.02 -$34.58 -$59.76
Operating activities
Depreciation $2.58 $3.96 $5.85 $3.3
Business acquisitions & disposals $1
Stock-based compensation $10.09 $9.3 $6.75 $3.95
Total cash flows from operations -$41.56 -$28.59 -$34.04 -$54.14
Investing activities
Capital expenditures -$1.29 -$0.59 -$0.11 -$0.75
Investments
Total cash flows from investing -$11.29 -$0.59 -$0.11 $0.25
Financing activities
Dividends paid
Sale and purchase of stock $25.42 $55.56 $21.75 $71.31
Net borrowings $19.91 $8.96 -$0.42 -$6.77
Total cash flows from financing $43.25 $64.96 $26.32 $63.42
Effect of exchange rate
Change in cash and equivalents -$9.6 $35.79 -$7.82 $9.52
Fundamentals
Market cap $1.01B
Enterprise value $978.14M
Shares outstanding 68.63M
Revenue $17.49M
EBITDA -$69.65M
EBIT -$72.23M
Net Income -$78.50M
Revenue Q/Q -15.47%
Revenue Y/Y 9.75%
P/E ratio -12.90
EV/Sales 55.93
EV/EBITDA -14.04
EV/EBIT -13.54
P/S ratio 57.88
P/B ratio 21.40
Book/Share 0.69
Cash/Share 1.22
EPS -$1.14
ROA -65.35%
ROE -132.16%
Debt/Equity 1.50
Net debt/EBITDA 0.18
Current ratio 4.85
Quick ratio 4.85